IMI to hold second quarter fiscal 2004 conference call & webcast TORONTO, Aug. 10 /PRNewswire-FirstCall/ -- IMI International Medical Innovations Inc. (TSX: IMI, Amex: IME) today announced it will hold a conference call and webcast on Thursday, August 12 at 10:30 a.m. (ET) to discuss the company's second quarter results. The event will be hosted by Dr. Brent Norton, President and CEO; Ron Hosking, Vice President and CFO; and Sarah Borg-Olivier, Director, Communications. Please dial in five minutes prior to start time: Date: Thursday, August 12, 2004 Time: 10:30 a.m. ET Webcast: http://www.imimedical.com/ or http://www.newswire.ca/ Conference Call Numbers: (416) 640-4127 (Toronto) (800) 814-4857 (North America) A webcast will be accessible for three months at http://www.imimedical.com/. A replay of the call will be available until August 19, 2004 by dialing (416) 640-1917 (Toronto) or (877) 289-8525 (North America) and entering access code 21070149 followed by the number sign. About IMI IMI is a world leader in predictive medicine, dedicated to developing rapid, non-invasive tests for the early detection of life-threatening diseases. IMI's cardiovascular products, which are branded as PREVU(x) Coronary Heart Disease Predictor, will be marketed and distributed worldwide by McNeil Consumer Healthcare (J&J). The company's cancer tests include ColorectAlert(TM), LungAlert(TM) and a breast cancer test. IMI's head office is located in Toronto, and its research and product development facility is at McMaster University in Hamilton, Ontario. For further information, please visit http://www.imimedical.com/. DATASOURCE: IMI International Medical Innovations Inc. CONTACT: Sarah Borg-Olivier, Director, Communications, (416) 222-3449,

Copyright